APA

Carter D. L., Asmar L., Barrera D., Caracandas J., Dakhil J. S., McCracken D., O'Rourke M. A., Rosenberg R. K., Boehm K. A., Ilegbodu D. & Reid R. L. (20090113). Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinoma. : Investigational new drugs.

Chicago

Carter Dennis L, Asmar Lina, Barrera David, Caracandas John, Dakhil J Shaker, McCracken Dean, O'Rourke Mark A, Rosenberg Richard K, Boehm Kristi A, Ilegbodu Des and Reid Robert L. 20090113. Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinoma. : Investigational new drugs.

Harvard

Carter D. L., Asmar L., Barrera D., Caracandas J., Dakhil J. S., McCracken D., O'Rourke M. A., Rosenberg R. K., Boehm K. A., Ilegbodu D. and Reid R. L. (20090113). Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinoma. : Investigational new drugs.

MLA

Carter Dennis L, Asmar Lina, Barrera David, Caracandas John, Dakhil J Shaker, McCracken Dean, O'Rourke Mark A, Rosenberg Richard K, Boehm Kristi A, Ilegbodu Des and Reid Robert L. Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinoma. : Investigational new drugs. 20090113.